![](/img/cover-not-exists.png)
Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor Efficacy
Albanese, C., Alzani, R., Amboldi, N., Avanzi, N., Ballinari, D., Brasca, M. G., Festuccia, C., Fiorentini, F., Locatelli, G., Pastori, W., Patton, V., Roletto, F., Colotta, F., Galvani, A., Isacchi,Volume:
9
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-10-0190
Date:
August, 2010
File:
PDF, 702 KB
english, 2010